Prolonged treatment with biologic agents for malignant glioma: A case study with high dose tamoxifen

Journal of Neuro-Oncology

Volumn 35, Issue 1, 1997, Pages 39-45

  Cloughesy, Mothy F ^a,b   Woods, Roger P ^a   Black, Keith L ^a,b   Couldwell, William T ^b   Law, Ron E ^c   Hinton, David R ^c  

^a Div of Biokinesiology and Physical Therapy   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Biologic agents; Malignant glioma; Study design; Tamoxifen

Indexed keywords

ANTIESTROGEN; TAMOXIFEN;

ADULT; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CASE REPORT; CELL DIFFERENTIATION; CYTOSTASIS; GLIOBLASTOMA; GROWTH INHIBITION; HUMAN; MALE;

ADULT; ANTINEOPLASTIC AGENTS, HORMONAL; DISEASE PROGRESSION; DRUG ADMINISTRATION SCHEDULE; GLIOMA; HUMANS; MALE; TAMOXIFEN;

EID: 8544229112     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005895616377     Document Type: Article

References (22)

1. Cairncross JG, Macdonald DR, Pexman JH, et al.: Steroid-induced CT changes in patients with recurrent malignant glioma. Neurology 38: 724-726, 1988
2. Couldwell WT, Hinton DR, He S, et al.: Protein kinase C inhibitors induce apoptosis in human malignant glioma cell lines. Febs Lett 345: 43-46, 1994
3. Couldwell WT, Hinton DR, Surnock AA, et al.: Treatment of recurrent malignant gliomas with chronic oral high-dose tamoxifen. Advances in brief. Clin Cancer Res 2: 619-622, 1996
4. Couldwell WT, Weiss MH, DeGiorgio CM, et al.: Clinical and radiographic response in a minority of patients with recurrent malignant gliomas treated with high-dose tamoxifen. Neurosurgery 32: 485-489, 1993
5. Couldwell WT, Weiss MH, Law RE, et al.: Paradoxical escalation of Ki-67 labeling with protein kinase inhibition of malignant gliomas. J Neurosurg 82: 461-468, 1995
6. Delattre J, Posner J: Neurological complications of chemotherapy and radiation therapy. In: Aminoff M. (ed) Neurology and General Medicine. Churchill Livingstone, New York 365-387, 1989
7. Gaspar LE, Fisher BJ, MacDonald DR, et al.: Malignant glioma - timing of response to radiation therapy. Int J Radiat Oncol Biol Phys 25: 877-879, 1993
8. Grenman S, Worsham M, Van Dyke D: Establishment and characterization of UM-EC-2, a tamoxifen-sensitive, estrogen receptor-negative human endometrial carcinoma cell line. Gynecol Oncol 37: 188-199, 1990
9. Kelloff G, Boone C, Crowell J, et al.: Surrogate endpoint biomarkers for phase II cancer chemoprevention trials. J Cell Biochem 19 (Suppl): 1-9, 1994
10. Legha S: Tamoxifen in the treatment of breast cancer. Ann Int Med 109: 219-228, 1988
11. Macdonald DR, Cascino TL, Schold SJ, et al.: Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 8: 1277-1280, 1990
12. O'Brian C, Housey G, Weinstein I: Specific and direct binding of protein kinase C to an immobilized tamoxifen analogue. Cancer Res 48: 3626-3629, 1988
13. O'Brian C, Liskamp R, Solomon D, et al.: Inhibition of protein kinase C by tamoxifen. Cancer Res 45: 2462-2465, 1985
14. Osborne R, Malik S, Slevin M: Tamoxifen in refactory ovarian cancer: The use of a loading dose schedule. Br J Cancer 57: 115-116, 1988
15. Pollack IF, Randall MS, Kristofik MP, et al.: Effect of tamoxifen on DNA synthesis and proliferation of human malignant glioma lines in vitro. Cancer Res 50: 7134-7138, 1990
16. Powis G, Alberts D: Inhibiting intracellular signalling as a strategy for cancer chemoprevention. Eur J Cancer 30A: 1138-1144, 1994
17. Szarka CE, Grana G, Engstrom PF: Chemoprevention of cancer. Curr Probl Cancer 18: 6-79, 1994
18. Urtasun R, Feldstein M, Partington J, et al.: Radiation and nitroimidazoles in supratentorial high-grade gliomas: A second clinical trial. Br J Cancer 46: 101-108, 1982
19. Watling CJ, Lee DH, Macdonald DR, et al.: Corticosteriod-induced magnetic resonance imaging changes in patients with recurrent malignant glioma. J Clin Oncol 12: 1886-1889, 1994
20. Weinstein I: Cancer prevention: Recent progress and future opportunities. Cancer Res (Suppl) 51: 5080-5085, 1991
21. Wood J, Green S, Shapairo W: The prognostic importance of tumor size in malignant gliomas: A computed tomographic scan study by the Brain Tumor Cooperative Group. J Clin Oncol 6: 338-343, 1988
22. Woods RP, Cherry SR, Mazziotta JC: Rapid automated algorithm for aligning and reslicing PET images. J Comput Assist Tomogr 16: 620-623, 1992